2-(2,6-dioxopiperidin-3-yl)-4-hydroxyisoindoline-1,3-dione
Modify Date: 2024-01-19 16:37:02
2-(2,6-dioxopiperidin-3-yl)-4-hydroxyisoindoline-1,3-dione structure
|
Common Name | 2-(2,6-dioxopiperidin-3-yl)-4-hydroxyisoindoline-1,3-dione | ||
|---|---|---|---|---|
| CAS Number | 5054-59-1 | Molecular Weight | 274.229 | |
| Density | 1.6±0.1 g/cm3 | Boiling Point | 568.3±45.0 °C at 760 mmHg | |
| Molecular Formula | C13H10N2O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 297.5±28.7 °C | |
Use of 2-(2,6-dioxopiperidin-3-yl)-4-hydroxyisoindoline-1,3-dioneE3 ligase Ligand 2 is a Ligand for E3 Ligase used in PROTAC technology. |
| Name | 2-(2,6-Dioxo-3-piperidinyl)-4-hydroxy-1H-isoindole-1,3(2H)-dione |
|---|---|
| Synonym | More Synonyms |
| Description | E3 ligase Ligand 2 is a Ligand for E3 Ligase used in PROTAC technology. |
|---|---|
| Related Catalog | |
| Target |
Ligand for E3 Ligase[1] |
| In Vitro | Thalidomide may exert anti-angiogenic effect in isolated blood vessels and endothelial cells. E3 ligase Ligand 2 is a putative hydroxylated thalidomide metabolite. E3 ligase Ligand 2 has weak anti-angiogenic activity (14% mean inhibition of blood vessel density at 100 mg). E3 ligase Ligand 2 does not have any anti-proliferative effect against the breast or neuroblastoma cells, but do possess appreciable anti-proliferative activity against the endothelial cells[1]. |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 568.3±45.0 °C at 760 mmHg |
| Molecular Formula | C13H10N2O5 |
| Molecular Weight | 274.229 |
| Flash Point | 297.5±28.7 °C |
| Exact Mass | 274.058960 |
| LogP | -0.20 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.679 |
| Storage condition | 2-8℃ |
| 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-hydroxy- |
| 2-(2,6-Dioxo-3-piperidinyl)-4-hydroxy-1H-isoindole-1,3(2H)-dione |
| 2-(2,6-dioxopiperidin-3-yl)-4-hydroxyisoindoline-1,3-dione |
| E3 ligase Ligand 2 |
| 4-Hydroxythalidomide |
| Pomalidomide Impurity 1 |